Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells

被引：0
|
作者：
Tomonori Tanei
Dong Soon Choi
Angel A. Rodriguez
Diana Hwang Liang
Lacey Dobrolecki
Madhumita Ghosh
Melissa D. Landis
Jenny C. Chang
机构：
[1] Methodist Cancer Center,Department of Surgery
[2] Houston Methodist Hospital,undefined
[3] Houston Methodist Hospital,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Epidermal Growth Factor Receptor; Cetuximab; Triple Negative Breast Cancer; Epidermal Growth Factor Receptor Signaling; Ixabepilone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Icaritin enhances the efficacy of cetuximab against triple-negative breast cancer cells
    Yin, Li
    Qi, Xiao-Wei
    Liu, Xun-Zhou
    Yang, Ze-Yu
    Cai, Rui-Li
    Cui, Hong-Juan
    Chen, Li
    Yu, Shi-Cang
    ONCOLOGY LETTERS, 2020, 19 (06) : 3950 - 3958
  • [22] Radioimmunoimaging of EGFR with pretargeting Cetuximab in triple negative breast cancer
    Lan, X.
    Yuan, L.
    Gai, Y.
    An, R.
    Zhang, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S746 - S746
  • [23] Synergistic antitumor effect of eribulin and vorinostat for triple negative breast cancer cells
    Oba, Takaaki
    Iesato, Asumi
    Miura, Kentaro
    Ito, Ken-ichi
    CANCER SCIENCE, 2018, 109 : 357 - 357
  • [24] Discovery of novel metformin derivatives with potent antitumor activity in combination with immunotherapy for treatment of triple-negative breast cancer
    Marquez-Garban, Diana C.
    Deng, Gang
    Comin-Anduix, Begonya
    Muhunthan, Vishaka
    Ma, Gaoyuan
    Murphy, Jennifer
    Garcia, Alejandro J.
    Yanes, Cristian D.
    Burton, Lorena R.
    Hamilton, Nalo
    Shackelford, David
    Jung, Michael E.
    Pietras, Richard J.
    CANCER RESEARCH, 2020, 80 (16)
  • [25] Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
    Tian, Jun
    Al Raffa, Fatmah
    Dai, Meiou
    Moamer, Alaa
    Khadang, Baharak
    Hachim, Ibrahim Y.
    Bakdounes, Khldoun
    Ali, Suhad
    Jean-Claude, Bertrand
    Lebrun, Jean-Jacques
    BRITISH JOURNAL OF CANCER, 2018, 119 (12) : 1495 - 1507
  • [26] Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
    Jun Tian
    Fatmah Al Raffa
    Meiou Dai
    Alaa Moamer
    Baharak Khadang
    Ibrahim Y. Hachim
    Khldoun Bakdounes
    Suhad Ali
    Bertrand Jean-Claude
    Jean-Jacques Lebrun
    British Journal of Cancer, 2018, 119 : 1495 - 1507
  • [27] Prelimenary results of a phase I/II of a combination of cetuximab and taxane for triple negative breast cancer patients
    Nechushtan, H.
    Steinberg, H.
    Peretz, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Inhibition of Notch signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
    Wei, Ping
    Qiu, Ming
    Jiang, Ivy
    Carroll, Christopher
    Han, Guangzhou
    Rymer, Isha
    Kraynov, Eugenia
    Wu, Aidong
    Thibault, Stephane
    Stone, Donna
    Gao, Yijie
    Sofia, Susan
    Gallo, Jorge
    White, Janet
    Li, Gary
    Yang, Jennifer
    Los, Gerrit
    CANCER RESEARCH, 2012, 72
  • [29] Targeting cancer stem-like cells in triple negative breast cancer
    Hossain, Fokhrul
    Bilyeu, Ayse D. Ucar
    Sorrentino, Claudia
    Crabtree, Judy
    Pannuti, Antonio
    Matossian, Margarite
    Burow, Matthew
    Golde, Todd
    Osborne, Barbara
    Miele, Lucio
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Activity of ixabepilone and PARP inhibitors in triple-negative breast cancer (TNBC) based on gene expression.
    Horak, C. E.
    Alexe, G.
    Baselga, J.
    Vahdat, L. T.
    Valero, V.
    Xing, G.
    Mukhopadhyay, P.
    Opatt, D. M.
    Sparano, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345